Leveraging DCT in Dementia Studies

The COVID-19 pandemic accelerated adoption of decentralized clinical research methods, including prompting research teams to explore ways to administer clinical outcome assessments remotely.

To enable trial continuity in a large, ongoing dementia trial, Signant’s clinical and scientific leadership helped a sponsor migrate from site-based clinician ratings to home-based assessments while maintaining measurement consistency and accuracy.

In episode nine of our "Clinical Viewpoints" video series, David Miller, Signant’s Clinical Vice President offers insights and best practices for ensuring data quality when implementing, administering, and scoring assessments remotely.